Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.
about
2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/εReduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Ménard apples, rich in polyphenolsAmelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptorMicroarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle.Cachectic skeletal muscle response to a novel bout of low-frequency stimulationMyogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration.Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3.β-agonists selectively modulate proinflammatory gene expression in skeletal muscle cells via non-canonical nuclear crosstalk mechanisms.Laminin-α1 LG4-5 domain binding to dystroglycan mediates muscle cell survival, growth, and the AP-1 and NF-κB transcription factors but also has adverse effects.Redox regulation of muscle adaptations to contractile activity and aging.Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice.Emerging drugs for Duchenne muscular dystrophyNuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexiaExpression of intercellular adhesion molecule-1 by myofibers in mdx miceDistinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.Removal of immunoglobulin-like domains from titin's spring segment alters titin splicing in mouse skeletal muscle and causes myopathy.Control of reactive oxygen species production in contracting skeletal muscle.Growth and Development Symposium: Impacts of inflammation on cattle growth and carcass merit.Nuclear factor-κB signalling and transcriptional regulation in skeletal muscle atrophy.Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy.Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis.The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy.Aberrant repair and fibrosis development in skeletal muscle.Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.Age and sex differences in human skeletal muscle fibrosis markers and transforming growth factor-β signaling.Reduced Appendicular Lean Body Mass, Muscle Strength, and Size of Type II Muscle Fibers in Patients with Spondyloarthritis versus Healthy Controls: A Cross-Sectional Study.
P2860
Q27677250-3866E725-96DE-48C1-AA67-7850889EBD94Q30066281-C7242013-CA84-4A47-B144-AFD06ABD1464Q30512264-8556CED1-9FF9-429C-8384-08AC84CD9029Q33647871-74F94387-838D-4444-8E80-EF31E23A0B45Q33673314-26A7137A-B6B4-4510-9D23-D8AFB05F2492Q34103354-1668645D-1FA7-42B6-B12D-AC547473EA52Q34181742-A08D0868-C75D-4B1A-B7E9-213C52BD7DD4Q34490064-E2203B86-390C-4164-870F-8D833BF4834DQ35113012-833FCA9E-6D6A-4A7F-880C-C240F5868826Q35849199-951283FC-A03A-476B-91C2-2AF26CC38C9DQ35921776-EEB96B6F-80A4-4BB3-A31E-805CB2A02018Q36333919-0DE01D59-258E-4DA1-BBCA-CE0F0232322CQ36363716-22BE88D7-EE88-4B26-974D-787A3BEED488Q37016738-ABFCA4D8-E212-4DFE-9BF7-085CB2FF37FDQ37591363-038973C5-83EB-4151-B8EC-FA27DDC0203BQ37593034-3F39441E-5538-4A78-AB72-8FA1DECC492FQ37727056-31C5C097-EB90-4B6A-8510-D129BA9A8558Q37893654-1CEC2038-1853-4174-B8B6-A534900A4058Q38009010-30C26062-05F4-4F51-A669-E8DAF7876B63Q38030905-4AD76AA9-03A2-49F5-8AB9-8467B14A3D8BQ38056065-006E65A9-EC6A-4B64-BF57-48B93E5A1FD0Q39629598-631B736A-F7C3-4DB8-A83E-E06B938E9AE3Q41717334-EFF98886-45AB-41DA-B684-CF1D2687DEF2Q41822988-0A45C372-E365-42C4-B533-F3FB7E127D79Q48312639-DF12D9A4-1351-4C26-8CA1-37B919779203Q51009227-1D937298-0B4F-4598-88A9-443445085F0AQ53021234-341BDD21-6E62-4658-A97C-F68B9F0E8364
P2860
Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Skeletal muscle diseases, infl ...... for therapeutic intervention.
@en
Skeletal muscle diseases, infl ...... for therapeutic intervention.
@nl
type
label
Skeletal muscle diseases, infl ...... for therapeutic intervention.
@en
Skeletal muscle diseases, infl ...... for therapeutic intervention.
@nl
prefLabel
Skeletal muscle diseases, infl ...... for therapeutic intervention.
@en
Skeletal muscle diseases, infl ...... for therapeutic intervention.
@nl
P2860
P1476
Skeletal muscle diseases, infl ...... for therapeutic intervention.
@en
P2093
Denis C Guttridge
Jennifer M Peterson
P2860
P304
P356
10.1080/08830180802302389
P577
2008-01-01T00:00:00Z